Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Human Papillomavirus testing and liquid-based cytology

Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix, a study in the Journal of the National Cancer Institute reports.

7 Jun 2006

Bill Gates puts his money where his mouth is again

Once again Microsoft founder Bill Gates is putting his money where his mouth is and the world's poorest women will benefit.

6 Jun 2006

New cervical cancer vaccine offers women 100% protection

Although there have been significant advancements in the screening and treatment of cancer, thousands of women every year contract cervical cancer.

6 Jun 2006

Vaccine against cervical cancer on track for FDA approval

According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.

17 May 2006

Combo of testing and vaccines a winner in fight against cervical cancer

According to experts in reproductive health, the combination of HPV testing with HPV vaccines is the best hope for preventing cervical cancer.

1 May 2006

Foot problems change social behaviour - but it doesn't have to be that way

With the average person taking 9,000 steps per day -- more than 600 miles each year -- when feet start to hurt or change in shape, it can really impact a person's life. In fact, according to a new survey, of people who report having foot issues in the past five years, two out of three report that these foot issues, which range from blisters to bunions and heel pain, have changed the kind of shoes they wear, how active they are, where and how far they walk, and so on.

23 Apr 2006

Cervical cancer vaccine gives women 4 years protection

Researchers say a vaccine that protects women against a virus that causes cervical cancer is effective for more than four years.

6 Apr 2006

Studies show HPV testing is more sensitive than current screening methods

The current technique for screening for cervical cancer involves collecting cells by way of a pap smear and examining them under a microscope. Although this method has reduced cervical cancer in countries where it is regularly used, it has several weaknesses.

3 Apr 2006

HPV vaccines provide hope for major international programmes of primary prevention

Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine.

3 Apr 2006

Human papillomavirus may be a risk factor in developing squamous cell carcinoma

The study, published in the March 15 issue of the Journal of the National Cancer Institute, used new technology to detect antibodies from a strain of HPV on skin cancer samples.

20 Mar 2006

Human papillomavirus infections and incidence of squamous cell and basal cell carcinomas of the skin

Infection with human papillomavirus (HPV) types called beta HPVs may be associated with an increased risk of developing a major type of skin cancer known as squamous cell carcinoma (SCC)

15 Mar 2006

New vaccines will protect against cancer

The leading cancer charity in Britain is predicting that thousands of cancers will be prevented every year as specific vaccines are developed.

13 Mar 2006

Human papillomavirus the main risk factor for cervical adenocarcinoma

Human papillomavirus (HPV) was found to be the main risk factor associated with increased incidence of an unusual type of cervical cancer called cervical adenocarcinoma, according to a study in the March 1 issue of the Journal of the National Cancer Institute.

1 Mar 2006

Cervical cancer vaccines in development

Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.

27 Feb 2006

New oral vaccine against Pseudomonas aeruginosa

A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.

23 Feb 2006

Teens think oral sex is not sex

According to a new national survey almost a quarter of sexually active Canadian teens between the ages of 14 and 17 have unprotected sex and 68 per cent have oral sex, although many are unaware that STIs can be transmitted through this particular sexual activity.

22 Feb 2006

Male circumcision, HIV and other STDs

A statistical review of the past medical files of more than 300 couples in Uganda, in which the female partner was HIV negative and the male was HIV positive, provides solid documentation of the protective effects of male circumcision in reducing the risk of infection among women.

16 Feb 2006

Study identifies compounds that overcome a specific type of resistance to chemotherapeutic-induced apoptosis

Treatment of human cancer is often impeded when cancer cells develop resistance to drugs that are designed to induce a type of programmed cell death called apoptosis.

16 Feb 2006

Cost-effectiveness analysis of HPV testing

A new study has found that using human papillomavirus (HPV) DNA testing to determine who should receive a cervical examination called colposcopy is a cost-effective management strategy for women with equivocal Pap test results known as ASCUS (atypical squamous cells of undetermined significance).

18 Jan 2006

HHS awards $56.9 million to tackle health disparities

HHS Secretary Mike Leavitt has announced the awarding of $56.9 million by the National Institutes of Health’s (NIH) National Center on Minority Health and Health Disparities (NCMHD).

10 Jan 2006